{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:47:39Z","timestamp":1790016459208,"version":"4.0.1"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,7,31]]},"DOI":"10.7759\/cureus.65883","type":"journal-article","created":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:07:57Z","timestamp":1722463677000},"source":"Crossref","is-referenced-by-count":3,"title":["Pathophysiology and Evolving Treatment Options of Septic Arthritis: A Narrative Review"],"prefix":"10.7759","author":[{"given":"Alan D","family":"Kaye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Driskell","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alana V","family":"Alvarez-Amado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Horace L","family":"Townsend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Vasterling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon  D","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahab","family":"Ahmadzadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam M","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahar","family":"Shekoohi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giustino","family":"Varrassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Septic arthritis. (2021). Accessed. January 7, 2024: https:\/\/www.hopkinsmedicine.org\/health\/conditions-and-diseases\/arthritis\/septic-arthritis."},{"key":"ref2","article-title":"Septic Arthritis","author":"Momodu II","year":"2023","unstructured":"Momodu II, Savaliya V. Septic Arthritis. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref3","unstructured":"Septic arthritis - symptoms & causes. (2024). Accessed. January 7, 2024: https:\/\/www.mayoclinic.org\/diseases-conditions\/bone-and-joint-infections\/symptoms-causes\/syc-20350755."},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1136\/ard.2006.058909","article-title":"Management of septic arthritis: a systematic review","volume":"66","author":"Mathews CJ","year":"2007","unstructured":"Mathews CJ, Kingsley G, Field M, et al.. Management of septic arthritis: a systematic review. Ann Rheum Dis. 2007, 66:440-5. 10.1136\/ard.2006.058909","journal-title":"Ann Rheum Dis"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.31138\/mjr.31.2.195","article-title":"The epidemiology and outcomes of septic arthritis in the maltese islands: a hospital-based retrospective cohort study","volume":"31","author":"Vassallo C","year":"2020","unstructured":"Vassallo C, Borg AA, Farrugia D, Mercieca C. The epidemiology and outcomes of septic arthritis in the maltese islands: a hospital-based retrospective cohort study. Mediterr J Rheumatol. 2020, 31:195-205. 10.31138\/mjr.31.2.195","journal-title":"Mediterr J Rheumatol"},{"key":"ref6","article-title":"Approach to septic arthritis","volume":"84","author":"Horowitz DL","year":"2011","unstructured":"Horowitz DL, Katzap E, Horowitz S, Barilla-LaBarca ML. Approach to septic arthritis. Am Fam Physician. 2011, 84:653-60.","journal-title":"Am Fam Physician"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2017.11.007","article-title":"Clinical outcomes involving patients that develop septic arthritis with methicillin sensitive Staphylococcus aureus versus methicillin resistant Staphylococcus aureus","volume":"15","author":"Combs K","year":"2018","unstructured":"Combs K, Cox K. Clinical outcomes involving patients that develop septic arthritis with methicillin sensitive Staphylococcus aureus versus methicillin resistant Staphylococcus aureus. J Orthop. 2018, 15:9-12. 10.1016\/j.jor.2017.11.007","journal-title":"J Orthop"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1179\/0001551213Z.00000000015","article-title":"Pneumococcal septic arthritis in adults: clinical analysis and review","volume":"69","author":"Belkhir L","year":"2014","unstructured":"Belkhir L, Rodriguez-Villalobos H, Vandercam B, Marot JC, Cornu O, Lambert M, Yombi JC. Pneumococcal septic arthritis in adults: clinical analysis and review. Acta Clin Belg. 2014, 69:40-6. 10.1179\/0001551213Z.00000000015","journal-title":"Acta Clin Belg"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/s1521-6942(02)00125-0","article-title":"Gonococcal arthritis","volume":"17","author":"Bardin T","year":"2003","unstructured":"Bardin T. Gonococcal arthritis. Best Pract Res Clin Rheumatol. 2003, 17:201-8. 10.1016\/s1521-6942(02)00125-0","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1097\/01.idc.0000168467.48814.8f","article-title":"Pseudomonas aeruginosa septic arthritis treatment failure with ceftazidime and amikacin in a chronic hemodialysis patient successfully treated with meropenem","volume":"13","author":"Mohan S","year":"2005","unstructured":"Mohan S, Syed F, Cunha B. Pseudomonas aeruginosa septic arthritis treatment failure with ceftazidime and amikacin in a chronic hemodialysis patient successfully treated with meropenem. Infect Dis Clin Pract. 2005, 13:200-202. 10.1097\/01.idc.0000168467.48814.8f","journal-title":"Infect Dis Clin Pract"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.68.12.6871-6878.2000","article-title":"Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells","volume":"68","author":"Sinha B","year":"2000","unstructured":"Sinha B, Francois P, Que YA, et al.. Heterologously expressed Staphylococcus aureus fibronectin-binding proteins are sufficient for invasion of host cells. Infect Immun. 2000, 68:6871-8. 10.1128\/IAI.68.12.6871-6878.2000","journal-title":"Infect Immun"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-016-2763-0","article-title":"The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus","volume":"35","author":"Foster TJ","year":"2016","unstructured":"Foster TJ. The remarkably multifunctional fibronectin binding proteins of Staphylococcus aureus. Eur J Clin Microbiol Infect Dis. 2016, 35:1923-31. 10.1007\/s10096-016-2763-0","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiu514","article-title":"Effect of biofilms on recalcitrance of Staphylococcal joint infection to antibiotic treatment","volume":"211","author":"Dastgheyb S","year":"2015","unstructured":"Dastgheyb S, Parvizi J, Shapiro IM, Hickok NJ, Otto M. Effect of biofilms on recalcitrance of Staphylococcal joint infection to antibiotic treatment. J Infect Dis. 2015, 211:641-50. 10.1093\/infdis\/jiu514","journal-title":"J Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2958.2001.02610.x","article-title":"The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence","volume":"41","author":"Holmes AR","year":"2001","unstructured":"Holmes AR, McNab R, Millsap KW, Rohde M, Hammerschmidt S, Mawdsley JL, Jenkinson HF. The pavA gene of Streptococcus pneumoniae encodes a fibronectin-binding protein that is essential for virulence. Mol Microbiol. 2001, 41:1395-408. 10.1046\/j.1365-2958.2001.02610.x","journal-title":"Mol Microbiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1021\/acsnano.7b07247","article-title":"Single molecule force spectroscopy reveals two-domain binding mode of pilus-1 tip protein RRGA of Streptococcus pneumoniae to fibronectin","volume":"12","author":"Becke TD","year":"2018","unstructured":"Becke TD, Ness S, G\u00fcrster R, et al.. Single molecule force spectroscopy reveals two-domain binding mode of pilus-1 tip protein RRGA of Streptococcus pneumoniae to fibronectin. ACS Nano. 2018, 12:549-58. 10.1021\/acsnano.7b07247","journal-title":"ACS Nano"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2958.2007.05908.x","article-title":"RrgA is a pilus-associated adhesin in Streptococcus pneumoniae","volume":"66","author":"Nelson AL","year":"2007","unstructured":"Nelson AL, Ries J, Bagnoli F, et al.. RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol. 2007, 66:329-40. 10.1111\/j.1365-2958.2007.05908.x","journal-title":"Mol Microbiol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1003373","article-title":"Pilus phase variation switches gonococcal adherence to invasion by caveolin-1-dependent host cell signaling","volume":"9","author":"Faulstich M","year":"2013","unstructured":"Faulstich M, B\u00f6ttcher JP, Meyer TF, Fraunholz M, Rudel T. Pilus phase variation switches gonococcal adherence to invasion by caveolin-1-dependent host cell signaling. PLoS Pathog. 2013, 9:e1003373. 10.1371\/journal.ppat.1003373","journal-title":"PLoS Pathog"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.15.4.527-544.2002","article-title":"Acute septic arthritis","volume":"15","author":"Shirtliff ME","year":"2002","unstructured":"Shirtliff ME, Mader JT. Acute septic arthritis. Clin Microbiol Rev. 2002, 15:527-44. 10.1128\/CMR.15.4.527-544.2002","journal-title":"Clin Microbiol Rev"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12395","article-title":"IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6\/TBK1-JNK\/NF-\u03baB pathways","volume":"144","author":"Lin D","year":"2014","unstructured":"Lin D, Li L, Sun Y, et al.. IL-17 regulates the expressions of RANKL and OPG in human periodontal ligament cells via TRAF6\/TBK1-JNK\/NF-\u03baB pathways. Immunology. 2014, 144:472-85. 10.1111\/imm.12395","journal-title":"Immunology"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jir266","article-title":"The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice","volume":"204","author":"Fei Y","year":"2011","unstructured":"Fei Y, Wang W, Kwiecinski J, et al.. The combination of a tumor necrosis factor inhibitor and antibiotic alleviates staphylococcal arthritis and sepsis in mice. J Infect Dis. 2011, 204:348-57. 10.1093\/infdis\/jir266","journal-title":"J Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-022-06151-w","article-title":"Risk factors for septic arthritis and multiple arthroscopic washouts: minimum 2-year follow-up at a major trauma centre","volume":"41","author":"Lu V","year":"2022","unstructured":"Lu V, Zhou A, Hussain HA, Thahir A, Krkovic M. Risk factors for septic arthritis and multiple arthroscopic washouts: minimum 2-year follow-up at a major trauma centre. Clin Rheumatol. 2022, 41:2513-23. 10.1007\/s10067-022-06151-w","journal-title":"Clin Rheumatol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-022-01822-z","article-title":"Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study.","volume":"83(3)","author":"Xie J","year":"2023","unstructured":"Xie J, Brash JT, Turkmen C, et al.. Risk of COVID-19 Diagnosis and Hospitalisation in Patients with Osteoarthritis or Back Pain Treated with Ibuprofen Compared to Other NSAIDs or Paracetamol: A Network Cohort Study.. Drugs. 2023, 83(3):249-263. 10.1007\/s40265-022-01822-z","journal-title":"Drugs"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/s0163-4453(98)90862-3","article-title":"Actinomyces pyogenes septic arthritis in a diabetic farmer","volume":"37","author":"Lynch M","year":"1998","unstructured":"Lynch M, O'Leary J, Murnaghan D, Cryan B. Actinomyces pyogenes septic arthritis in a diabetic farmer. J Infect. 1998, 37:71-3. 10.1016\/s0163-4453(98)90862-3","journal-title":"J Infect"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/1749-799X-3-33","article-title":"Septic arthritis in patients with rheumatoid arthritis","volume":"3","author":"Al-Ahaideb A","year":"2008","unstructured":"Al-Ahaideb A. Septic arthritis in patients with rheumatoid arthritis. J Orthop Surg Res. 2008, 3:33. 10.1186\/1749-799X-3-33","journal-title":"J Orthop Surg Res"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3109\/17453679108994458","article-title":"The infected knee arthroplasty. A 6-year follow-up of 357 cases","volume":"62","author":"Bengtson S","year":"1991","unstructured":"Bengtson S, Knutson K. The infected knee arthroplasty. A 6-year follow-up of 357 cases. Acta Orthop Scand. 1991, 62:301-11. 10.3109\/17453679108994458","journal-title":"Acta Orthop Scand"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1016\/j.jcot.2013.11.005","article-title":"Bone cement","volume":"4","author":"Vaishya R","year":"2013","unstructured":"Vaishya R, Chauhan M, Vaish A. Bone cement. J Clin Orthop Trauma. 2013, 4:157-63. 10.1016\/j.jcot.2013.11.005","journal-title":"J Clin Orthop Trauma"},{"key":"ref27","unstructured":"Differentiating lyme arthritis from septic arthritis. clues uncovered. (2011). Accessed: January 8, 2024: https:\/\/www.hcplive.com\/view\/differentiating-lyme-arthritis-septic-arthritis-clues-uncovered."},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.1016\/j.idc.2015.02.004","article-title":"Diagnosis and treatment of Lyme arthritis","volume":"29","author":"Arvikar SL","year":"2015","unstructured":"Arvikar SL, Steere AC. Diagnosis and treatment of Lyme arthritis. Infect Dis Clin North Am. 2015, 29:269-80. 10.1016\/j.idc.2015.02.004","journal-title":"Infect Dis Clin North Am"},{"key":"ref29","unstructured":"Joint aspiration (arthrocentesis). background, indications, contraindications. (2024). Accessed: January 8, 2024: https:\/\/emedicine.medscape.com\/article\/2094114-overview."},{"key":"ref30","article-title":"Third-Generation Cephalosporins","author":"Arumugham VB","year":"2023","unstructured":"Arumugham VB, Gujarathi R, Cascella M. Third-Generation Cephalosporins. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref31","article-title":"Vancomycin","author":"Patel S","year":"2023","unstructured":"Patel S, Preuss CV, Bernice F. Vancomycin. StatPearls Publishing, Treasure Island, FL; 2023."},{"key":"ref32","unstructured":"Nafcillin. indications, uses, dosage, drugs interactions, side effects. (2023). Accessed: January 8, 2024: http:\/\/2023."},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.5811\/westjem.2018.10.40974","article-title":"Evaluation and management of septic arthritis and its mimics in the emergency department","volume":"20","author":"Long B","year":"2019","unstructured":"Long B, Koyfman A, Gottlieb M. Evaluation and management of septic arthritis and its mimics in the emergency department. West J Emerg Med. 2019, 20:331-41. 10.5811\/westjem.2018.10.40974","journal-title":"West J Emerg Med"},{"key":"ref34","article-title":"Diagnosis and management of osteomyelitis","volume":"84","author":"Hatzenbuehler J","year":"2011","unstructured":"Hatzenbuehler J, Pulling TJ. Diagnosis and management of osteomyelitis. Am Fam Physician. 2011, 84:1027-33.","journal-title":"Am Fam Physician"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph13060539","article-title":"A case of acute osteomyelitis: an update on diagnosis and treatment","volume":"13","author":"Chiappini E","year":"2016","unstructured":"Chiappini E, Mastrangelo G, Lazzeri S. A case of acute osteomyelitis: an update on diagnosis and treatment. Int J Environ Res Public Health. 2016, 13:539. 10.3390\/ijerph13060539","journal-title":"Int J Environ Res Public Health"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1016\/j.jor.2016.10.004","article-title":"Osteomyelitis: recent advances in pathophysiology and therapeutic strategies","volume":"14","author":"Birt MC","year":"2017","unstructured":"Birt MC, Anderson DW, Bruce Toby E, Wang J. Osteomyelitis: recent advances in pathophysiology and therapeutic strategies. J Orthop. 2017, 14:45-52. 10.1016\/j.jor.2016.10.004","journal-title":"J Orthop"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms17060855","article-title":"Update on the management of pediatric acute osteomyelitis and septic arthritis","volume":"17","author":"Castellazzi L","year":"2016","unstructured":"Castellazzi L, Mantero M, Esposito S. Update on the management of pediatric acute osteomyelitis and septic arthritis. Int J Mol Sci. 2016, 17:855. 10.3390\/ijms17060855","journal-title":"Int J Mol Sci"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199205283262206","article-title":"Nontraumatic necrosis of bone (osteonecrosis)","volume":"326","author":"Mankin HJ","year":"1992","unstructured":"Mankin HJ. Nontraumatic necrosis of bone (osteonecrosis). N Engl J Med. 1992, 326:1473-9. 10.1056\/NEJM199205283262206","journal-title":"N Engl J Med"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.5312\/wjo.v6.i8.590","article-title":"Current concepts on osteonecrosis of the femoral head","volume":"6","author":"Moya-Angeler J","year":"2015","unstructured":"Moya-Angeler J, Gianakos AL, Villa JC, Ni A, Lane JM. Current concepts on osteonecrosis of the femoral head. World J Orthop. 2015, 6:590-601. 10.5312\/wjo.v6.i8.590","journal-title":"World J Orthop"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.5435\/JAAOS-22-07-455","article-title":"Osteonecrosis of the femoral head: evaluation and treatment","volume":"22","author":"Zalavras CG","year":"2014","unstructured":"Zalavras CG, Lieberman JR. Osteonecrosis of the femoral head: evaluation and treatment. J Am Acad Orthop Surg. 2014, 22:455-64. 10.5435\/JAAOS-22-07-455","journal-title":"J Am Acad Orthop Surg"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keg297","article-title":"Concomitant septic and gouty arthritis--an analysis of 30 cases","volume":"42","author":"Yu KH","year":"2003","unstructured":"Yu KH, Luo SF, Liou LB, Wu YJ, Tsai WP, Chen JY, Ho HH. Concomitant septic and gouty arthritis--an analysis of 30 cases. Rheumatology (Oxford). 2003, 42:1062-6. 10.1093\/rheumatology\/keg297","journal-title":"Rheumatology (Oxford)"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3899\/jrheum.110368","article-title":"Concomitant septic arthritis in crystal monoarthritis","volume":"39","author":"Papanicolas LE","year":"2012","unstructured":"Papanicolas LE, Hakendorf P, Gordon DL. Concomitant septic arthritis in crystal monoarthritis. J Rheumatol. 2012, 39:157-60. 10.3899\/jrheum.110368","journal-title":"J Rheumatol"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43112","article-title":"Lyme disease and post-treatment Lyme disease syndrome: current and developing treatment options","volume":"15","author":"Talbot NC","year":"2023","unstructured":"Talbot NC, Spillers NJ, Luther P, et al.. Lyme disease and post-treatment Lyme disease syndrome: current and developing treatment options. Cureus. 2023, 15:e43112. 10.7759\/cureus.43112","journal-title":"Cureus"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.4065\/83.5.566","article-title":"Diagnosis and treatment of Lyme disease","volume":"83","author":"Bratton RL","year":"2008","unstructured":"Bratton RL, Whiteside JW, Hovan MJ, Engle RL, Edwards FD. Diagnosis and treatment of Lyme disease. Mayo Clin Proc. 2008, 83:566-71. 10.4065\/83.5.566","journal-title":"Mayo Clin Proc"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1097\/RHU.0000000000001513","article-title":"Stages of Lyme arthritis","volume":"27","author":"Miller JB","year":"2021","unstructured":"Miller JB, Aucott JN. Stages of Lyme arthritis. J Clin Rheumatol. 2021, 27:e540-6. 10.1097\/RHU.0000000000001513","journal-title":"J Clin Rheumatol"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1016\/j.cll.2010.01.003","article-title":"Lyme disease","volume":"30","author":"Murray TS","year":"2010","unstructured":"Murray TS, Shapiro ED. Lyme disease. Clin Lab Med. 2010, 30:311-28. 10.1016\/j.cll.2010.01.003","journal-title":"Clin Lab Med"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1016\/j.jadohealth.2008.12.007","article-title":"Reactive arthritis: a review","volume":"44","author":"Kim PS","year":"2009","unstructured":"Kim PS, Klausmeier TL, Orr DP. Reactive arthritis: a review. J Adolesc Health. 2009, 44:309-15. 10.1016\/j.jadohealth.2008.12.007","journal-title":"J Adolesc Health"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2014.01.005","article-title":"Diagnosis and classification of reactive arthritis","volume":"13","author":"Selmi C","year":"2014","unstructured":"Selmi C, Gershwin ME. Diagnosis and classification of reactive arthritis. Autoimmun Rev. 2014, 13:546-9. 10.1016\/j.autrev.2014.01.005","journal-title":"Autoimmun Rev"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2024.101970","article-title":"Inflammatory or non-inflammatory pain in inflammatory arthritis - how to differentiate it? [IN PRESS]","author":"Sarzi-Puttini P","year":"2024","unstructured":"Sarzi-Puttini P, Pellegrino G, Giorgi V, et al.. Inflammatory or non-inflammatory pain in inflammatory arthritis - how to differentiate it? [IN PRESS]. Best Pract Res Clin Rheumatol. 2024, 101970. 10.1016\/j.berh.2024.101970","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30173-8","article-title":"Rheumatoid arthritis","volume":"388","author":"Smolen JS","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis. Lancet. 2016, 388:2023-38. 10.1016\/S0140-6736(16)30173-8","journal-title":"Lancet"},{"key":"ref51","article-title":"Diagnosis and management of rheumatoid arthritis","volume":"84","author":"Wasserman AM","year":"2011","unstructured":"Wasserman AM. Diagnosis and management of rheumatoid arthritis. Am Fam Physician. 2011, 84:1245-52.","journal-title":"Am Fam Physician"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcl.2014.08.002","article-title":"Transient synovitis, septic hip, and Legg-Calv\u00e9-Perthes disease: an approach to the correct diagnosis","volume":"61","author":"Cook PC","year":"2014","unstructured":"Cook PC. Transient synovitis, septic hip, and Legg-Calv\u00e9-Perthes disease: an approach to the correct diagnosis. Pediatr Clin North Am. 2014, 61:1109-18. 10.1016\/j.pcl.2014.08.002","journal-title":"Pediatr Clin North Am"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1097\/BPB.0b013e328363b5a3","article-title":"Transient synovitis of the hip: a comprehensive review","volume":"23","author":"Nouri A","year":"2014","unstructured":"Nouri A, Walmsley D, Pruszczynski B, Synder M. Transient synovitis of the hip: a comprehensive review. J Pediatr Orthop B. 2014, 23:32-6. 10.1097\/BPB.0b013e328363b5a3","journal-title":"J Pediatr Orthop B"},{"key":"ref54","article-title":"Common superficial bursitis","volume":"95","author":"Khodaee M","year":"2017","unstructured":"Khodaee M. Common superficial bursitis. Am Fam Physician. 2017, 95:224-31.","journal-title":"Am Fam Physician"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1540-0","article-title":"Morbimortality in adult patients with septic arthritis: a three-year hospital-based study","volume":"16","author":"Ferrand J","year":"2016","unstructured":"Ferrand J, El Samad Y, Brunschweiler B, et al.. Morbimortality in adult patients with septic arthritis: a three-year hospital-based study. BMC Infect Dis. 2016, 16:239. 10.1186\/s12879-016-1540-0","journal-title":"BMC Infect Dis"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1097\/00005792-199309000-00002","article-title":"Polyarticular septic arthritis","volume":"72","author":"Dubost JJ","year":"1993","unstructured":"Dubost JJ, Fis I, Denis P, et al.. Polyarticular septic arthritis. Medicine (Baltimore). 1993, 72:296-310. 10.1097\/00005792-199309000-00002","journal-title":"Medicine (Baltimore)"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1177\/2309499019860468","article-title":"The difference between native septic arthritis and prosthetic joint infections: a review of literature","volume":"27","author":"Roerdink RL","year":"2019","unstructured":"Roerdink RL, Huijbregts HJ, van Lieshout AW, Dietvorst M, van der Zwaard BC. The difference between native septic arthritis and prosthetic joint infections: a review of literature. J Orthop Surg (Hong Kong). 2019, 27:2309499019860468. 10.1177\/2309499019860468","journal-title":"J Orthop Surg (Hong Kong)"},{"key":"ref58","unstructured":"Acute septic arthritis. (2002). Accessed. January 8, 2024: https:\/\/journals.asm.org\/doi\/full\/10.1128\/cmr.15.4.527-544.2002."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/s12891-021-04383-6","article-title":"Novel therapeutic interventions towards improved management of septic arthritis","volume":"22","author":"Wang J","year":"2021","unstructured":"Wang J, Wang L. Novel therapeutic interventions towards improved management of septic arthritis. BMC Musculoskelet Disord. 2021, 22:530. 10.1186\/s12891-021-04383-6","journal-title":"BMC Musculoskelet Disord"},{"key":"ref60","article-title":"Septic arthritis: diagnosis and treatment","volume":"104","author":"Earwood JS","year":"2021","unstructured":"Earwood JS, Walker TR, Sue GJ. Septic arthritis: diagnosis and treatment. Am Fam Physician. 2021, 104:589-97.","journal-title":"Am Fam Physician"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780381215","article-title":"Risk factors for septic arthritis in patients with joint disease. A prospective study","volume":"38","author":"Kaandorp CJ","year":"1995","unstructured":"Kaandorp CJ, Van Schaardenburg D, Krijnen P, Habbema JD, van de Laar MA. Risk factors for septic arthritis in patients with joint disease. A prospective study. Arthritis Rheum. 1995, 38:1819-25. 10.1002\/art.1780381215","journal-title":"Arthritis Rheum"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1308\/003588413X13511609955292","article-title":"Polyarticular septic arthritis in an immunocompetent patient","volume":"95","author":"Clements J","year":"2013","unstructured":"Clements J, Dinneen A, Heilpern G. Polyarticular septic arthritis in an immunocompetent patient. Ann R Coll Surg Engl. 2013, 95:e34-5. 10.1308\/003588413X13511609955292","journal-title":"Ann R Coll Surg Engl"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1016\/j.berh.2011.02.001","article-title":"Septic arthritis","volume":"25","author":"Garc\u00eda-Arias M","year":"2011","unstructured":"Garc\u00eda-Arias M, Balsa A, Mola EM. Septic arthritis. Best Pract Res Clin Rheumatol. 2011, 25:407-21. 10.1016\/j.berh.2011.02.001","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-198610000-00011","article-title":"Infection versus disease activity in rheumatoid arthritis: eight years' experience","volume":"79","author":"Blackburn WD Jr","year":"1986","unstructured":"Blackburn WD Jr, Dunn TL, Alarc\u00f3n GS. Infection versus disease activity in rheumatoid arthritis: eight years' experience. South Med J. 1986, 79:1238-41. 10.1097\/00007611-198610000-00011","journal-title":"South Med J"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-010-1602-3","article-title":"Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis","volume":"32","author":"Zamani B","year":"2012","unstructured":"Zamani B, Jamali R, Ehteram H. Synovial fluid adenosine deaminase and high-sensitivity C-reactive protein activity in differentiating monoarthritis. Rheumatol Int. 2012, 32:183-8. 10.1007\/s00296-010-1602-3","journal-title":"Rheumatol Int"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.arth.2018.09.069","article-title":"General assembly, diagnosis, definitions: proceedings of international consensus on orthopedic infections","volume":"34","author":"Elkins JM","year":"2019","unstructured":"Elkins JM, Kates S, Lange J, et al.. General assembly, diagnosis, definitions: proceedings of international consensus on orthopedic infections. J Arthroplasty. 2019, 34:S181-5. 10.1016\/j.arth.2018.09.069","journal-title":"J Arthroplasty"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1054\/arth.2000.4637","article-title":"Infected total knee arthroplasty treated by arthroscopic irrigation and d\u00e9bridement","volume":"15","author":"Waldman BJ","year":"2000","unstructured":"Waldman BJ, Hostin E, Mont MA, Hungerford DS. Infected total knee arthroplasty treated by arthroscopic irrigation and d\u00e9bridement. J Arthroplasty. 2000, 15:430-6. 10.1054\/arth.2000.4637","journal-title":"J Arthroplasty"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1267","article-title":"Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies","volume":"24","author":"Hancock RE","year":"2006","unstructured":"Hancock RE, Sahl HG. Antimicrobial and host-defense peptides as new anti-infective therapeutic strategies. Nat Biotechnol. 2006, 24:1551-7. 10.1038\/nbt1267","journal-title":"Nat Biotechnol"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2016.00194","article-title":"Antimicrobial peptides: an emerging category of therapeutic agents","volume":"6","author":"Mahlapuu M","year":"2016","unstructured":"Mahlapuu M, H\u00e5kansson J, Ringstad L, Bj\u00f6rn C. Antimicrobial peptides: an emerging category of therapeutic agents. Front Cell Infect Microbiol. 2016, 6:194. 10.3389\/fcimb.2016.00194","journal-title":"Front Cell Infect Microbiol"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-018-9465-0","article-title":"Antimicrobial peptides: the Achilles' heel of antibiotic resistance?","volume":"11","author":"Lewies A","year":"2019","unstructured":"Lewies A, Du Plessis LH, Wentzel JF. Antimicrobial peptides: the Achilles' heel of antibiotic resistance?. Probiotics Antimicrob Proteins. 2019, 11:370-81. 10.1007\/s12602-018-9465-0","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1128\/AAC.03163-14","article-title":"A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms","volume":"58","author":"Reffuveille F","year":"2014","unstructured":"Reffuveille F, de la Fuente-N\u00fa\u00f1ez C, Mansour S, Hancock RE. A broad-spectrum antibiofilm peptide enhances antibiotic action against bacterial biofilms. Antimicrob Agents Chemother. 2014, 58:5363-71. 10.1128\/AAC.03163-14","journal-title":"Antimicrob Agents Chemother"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1016\/j.joca.2019.06.007","article-title":"Antimicrobial peptides derived from the cartilage.-specific C-type Lectin Domain Family 3 Member A (CLEC3A) - potential in the prevention and treatment of septic arthritis","volume":"27","author":"Elezagic D","year":"2019","unstructured":"Elezagic D, M\u00f6rgelin M, Hermes G, et al.. Antimicrobial peptides derived from the cartilage.-specific C-type Lectin Domain Family 3 Member A (CLEC3A) - potential in the prevention and treatment of septic arthritis. Osteoarthritis Cartilage. 2019, 27:1564-73. 10.1016\/j.joca.2019.06.007","journal-title":"Osteoarthritis Cartilage"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.3389\/fmicb.2018.00667","article-title":"Lyetxi-b, a synthetic peptide derived from lycosa erythrognatha spider venom, shows potent antibiotic activity in vitro and in vivo","volume":"9","author":"Reis PV","year":"2018","unstructured":"Reis PV, Boff D, Verly RM, et al.. Lyetxi-b, a synthetic peptide derived from lycosa erythrognatha spider venom, shows potent antibiotic activity in vitro and in vivo. Front Microbiol. 2018, 9:667. 10.3389\/fmicb.2018.00667","journal-title":"Front Microbiol"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1136\/ard.59.6.455","article-title":"Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis","volume":"59","author":"Yoshihara Y","year":"2000","unstructured":"Yoshihara Y, Nakamura H, Obata K, Yamada H, Hayakawa T, Fujikawa K, Okada Y. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000, 59:455-61. 10.1136\/ard.59.6.455","journal-title":"Ann Rheum Dis"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.2741\/1817","article-title":"Matrix metalloproteinases: role in arthritis","volume":"11","author":"Burrage PS","year":"2006","unstructured":"Burrage PS, Mix KS, Brinckerhoff CE. Matrix metalloproteinases: role in arthritis. Front Biosci. 2006, 11:529-43. 10.2741\/1817","journal-title":"Front Biosci"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2004.12.005","article-title":"Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis","volume":"38","author":"Gjertsson I","year":"2005","unstructured":"Gjertsson I, Innocenti M, Matrisian LM, Tarkowski A. Metalloproteinase-7 contributes to joint destruction in Staphylococcus aureus induced arthritis. Microb Pathog. 2005, 38:97-105. 10.1016\/j.micpath.2004.12.005","journal-title":"Microb Pathog"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1016\/j.micpath.2016.08.021","article-title":"Neutralization of MMP-2 protects Staphylococcus aureus infection induced septic arthritis in mice and regulates the levels of cytokines","volume":"99","author":"Sultana S","year":"2016","unstructured":"Sultana S, Adhikary R, Nandi A, Bishayi B. Neutralization of MMP-2 protects Staphylococcus aureus infection induced septic arthritis in mice and regulates the levels of cytokines. Microb Pathog. 2016, 99:148-61. 10.1016\/j.micpath.2016.08.021","journal-title":"Microb Pathog"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2018.00962","article-title":"Interleukin-33 receptor (ST2) deficiency improves the outcome of Staphylococcus aureus-induced septic arthritis","volume":"9","author":"Staurengo-Ferrari L","year":"2018","unstructured":"Staurengo-Ferrari L, Trevelin SC, Fattori V, et al.. Interleukin-33 receptor (ST2) deficiency improves the outcome of Staphylococcus aureus-induced septic arthritis. Front Immunol. 2018, 9:962. 10.3389\/fimmu.2018.00962","journal-title":"Front Immunol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jis295","article-title":"Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritis","volume":"206","author":"Henningsson L","year":"2012","unstructured":"Henningsson L, Jirholt P, Bogest\u00e5l YR, et al.. Interleukin 15 mediates joint destruction in Staphylococcus aureus arthritis. J Infect Dis. 2012, 206:687-96. 10.1093\/infdis\/jis295","journal-title":"J Infect Dis"},{"key":"ref80","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.160.10.5082","article-title":"Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth","volume":"160","author":"Hultgren O","year":"1998","unstructured":"Hultgren O, Kopf M, Tarkowski A. Staphylococcus aureus-induced septic arthritis and septic death is decreased in IL-4-deficient mice: role of IL-4 as promoter for bacterial growth. J Immunol. 1998, 160:5082-7.","journal-title":"J Immunol"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1002\/art.10170","article-title":"The beneficial effect of interleukin-12 on arthritis induced by group B Streptococci is mediated by interferon-gamma and interleukin-10 production","volume":"46","author":"Puliti M","year":"2002","unstructured":"Puliti M, von Hunolstein C, Bistoni F, Mosci P, Orefici G, Tissi L. The beneficial effect of interleukin-12 on arthritis induced by group B Streptococci is mediated by interferon-gamma and interleukin-10 production. Arthritis Rheum. 2002, 46:806-17. 10.1002\/art.10170","journal-title":"Arthritis Rheum"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.2002.01999.x","article-title":"Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance","volume":"130","author":"Gjertsson I","year":"2002","unstructured":"Gjertsson I, Hultgren OH, Tarkowski A. Interleukin-10 ameliorates the outcome of Staphylococcus aureus arthritis by promoting bacterial clearance. Clin Exp Immunol. 2002, 130:409-14. 10.1046\/j.1365-2249.2002.01999.x","journal-title":"Clin Exp Immunol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/277824-pathophysiology-and-evolving-treatment-options-of-septic-arthritis-a-narrative-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T22:08:09Z","timestamp":1722463689000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/277824-pathophysiology-and-evolving-treatment-options-of-septic-arthritis-a-narrative-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,31]]},"references-count":82,"URL":"https:\/\/doi.org\/10.7759\/cureus.65883","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7,31]]}}}